STOCK TITAN

Hanover Bancorp, Inc. (HNVR) Financials

HNVR
Trailing 12 months to June 30, 2026
Revenue $75.3M +4.9% YoY
Net Income $9.5M -17.0% YoY
EPS (Diluted) $1.27 -17.0% YoY
Free Cash Flow $25.8M +362.9% YoY
Market Cap $187.9M as of Sep 19, 2026
Price / Sales 2.5x on $75.3M revenue, trailing 12 months to June 30, 2026
Price / Earnings 19.9x on $9.5M net income, trailing 12 months to June 30, 2026
Price / Book 0.9x on $202.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HNVR SEC filings page.

Hanover Bancorp, Inc. (HNVR) reported $75.3M in revenue over the twelve months to Jun 30, 2026, up 4.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HNVR FY2025

Funding costs compress earnings even as revenue recovers, leaving an asset-heavy balance sheet with thin returns.

In FY2025, revenue rose to $73.3M while net income fell to $7.5M. That divergence, alongside interest expense of $70.0M, indicates that funding economics—not sales volume—dominated the earnings outcome.

Operating cash flow recovered to $13.1M and nearly converted into free cash flow of $12.2M. The narrow gap indicates reported cash generation was not being consumed by physical reinvestment, although bank working-balance movements can make operating cash flow differ from earnings.

Assets expanded to $2.4B while reported debt-to-equity remained high at 10.9x, so growth continues through a liability-heavy structure rather than a large equity cushion. Return on assets fell from 0.5% in FY2024 to 0.3% in FY2025, showing that the larger asset base did not translate proportionally into profit.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 29 / 100
Financial Health Score 29/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Hanover Bancorp, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
25

Hanover Bancorp, Inc. earned a return on assets of 0.3% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is down from 0.5% the prior year. Earnings ranks banks on that return over three years, and Hanover Bancorp, Inc. scores 25/100 among other banks.

Growth
49

Hanover Bancorp, Inc. reported revenue of $73.3M in fiscal year 2025, against $68.4M in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Hanover Bancorp, Inc. scores 49/100 among other banks.

Capital
12

Hanover Bancorp, Inc. funded 8.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $200.3M of equity against $2.4B of assets. Capital ranks banks on that cushion, and Hanover Bancorp, Inc. scores 12/100 among other banks.

Efficiency
32

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Hanover Bancorp, Inc. scores 32/100 on it among other banks.

Credit Quality
20

Credit Quality measures the money a bank set aside for loans it expects to go bad, against the size of the loan book it set that money aside for. Hanover Bancorp, Inc. scores 20/100 on it among other banks.

Stability
38

Hanover Bancorp, Inc. reported net income of $7.5M in fiscal year 2025, against $12.3M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Hanover Bancorp, Inc. scores 38/100 among other banks.

Piotroski F-Score Partial
5/6

Hanover Bancorp, Inc. passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.74x

For every $1 of reported earnings, Hanover Bancorp, Inc. generates $1.74 in operating cash flow ($13.1M OCF vs $7.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$19.6M
YoY+6.6%
QoQ+2.4%
5Y CAGR+12.0%

Hanover Bancorp, Inc. generated $19.6M in revenue in Q2 2026. This represents an increase of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Net Income
$4.1M
YoY+66.4%
QoQ+116.9%
5Y CAGR+79.0%

Hanover Bancorp, Inc. reported $4.1M in net income in Q2 2026. This represents an increase of 66.4% from the same quarter a year earlier. Against the prior quarter it is up 116.9%.

EPS (Diluted)
$0.55
YoY+66.7%
QoQ+120.0%
5Y CAGR+61.5%

Hanover Bancorp, Inc. earned $0.55 per diluted share (EPS) in Q2 2026. This represents an increase of 66.7% from the same quarter a year earlier. Against the prior quarter it is up 120.0%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$18.0M
YoY+972.8%
QoQ+767.4%
5Y CAGR+34.7%

Hanover Bancorp, Inc. generated $18.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 972.8% from the same quarter a year earlier. Against the prior quarter it is up 767.4%.

Cash & Debt
$141.2M
YoY-14.2%
QoQ-27.4%
5Y CAGR-3.7%

Hanover Bancorp, Inc. held $141.2M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.10
YoY0.0%
QoQ0.0%

Hanover Bancorp, Inc. paid $0.10 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
7M
YoY-2.2%
QoQ-1.4%
5Y CAGR+4.9%

Hanover Bancorp, Inc. had 7M shares outstanding in Q2 2026. This represents a decrease of 2.2% from the same quarter a year earlier. Against the prior quarter it is down 1.4%.

Margins & Returns

Net Margin
20.8%
YoY+7.5pp
QoQ+11.0pp
5Y change+18.8pp

Hanover Bancorp, Inc.'s net profit margin was 20.8% in Q2 2026, showing the share of revenue converted to profit. This is up 7.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.0 percentage points.

Return on Equity
2.0%
YoY+0.8pp
QoQ+1.1pp
5Y change+1.8pp

Hanover Bancorp, Inc.'s ROE was 2.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures
$442K
YoY+391.1%
QoQ+140.2%
5Y CAGR+0.6%

Hanover Bancorp, Inc. invested $442K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 391.1% from the same quarter a year earlier. Against the prior quarter it is up 140.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

HNVR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HNVR quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$19.6M+6.6%$19.1M+4.1%$18.6M+3.3%$18.0M+5.6%$18.4M+8.8%$18.4M+11.2%$18.0M+13.1%$17.1M+10.0%
SG&A Expenses$7.4M+5.2%$10.1M+40.0%$6.9M+2.7%$6.8M-1.0%$7.0M+7.8%$7.2M+30.0%$6.7M+27.8%$6.8M+27.8%
Interest Expense$15.3M-11.4%$15.9M-12.5%$16.8M-12.9%$17.8M-15.4%$17.3M-14.5%$18.2M-6.6%$19.2M+4.1%$21.0M+22.5%
Income Tax$1.4M+44.1%$1.1M+349.2%$103K-92.0%$1.2M+9.3%$940K+198.4%$244K-81.9%$1.3M+1.0%$1.1M-7.5%
Net Income$4.1M+66.4%$1.9M+23.2%$33K-99.2%$3.5M-1.4%$2.4M+189.5%$1.5M-62.5%$3.9M+3.7%$3.5M+0.5%
EPS (Basic)$0.55+66.7%$0.25+25.0%$0.01-98.1%$0.47-2.1%$0.33+200.0%$0.20-63.6%$0.53+3.9%$0.480.0%
EPS (Diluted)$0.55+66.7%$0.25+25.0%$0.00-100.0%$0.47-2.1%$0.33+200.0%$0.20-63.6%$0.52+2.0%$0.480.0%
Diluted Shares (Avg)7M-1.0%7M+0.1%N/A7M+1.2%7M+1.2%7M+0.9%N/A7M+0.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

HNVR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HNVR quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$2.3B+1.1%$2.4B+3.5%$2.4B+3.1%$2.3B+0.2%$2.3B-0.8%$2.3B-0.7%$2.3B+1.9%$2.3B+8.3%
Cash & Equivalents$141.2M-14.2%$194.4M+21.4%$208.9M+28.3%$167.6M+18.6%$164.5M+16.6%$160.2M+17.4%$162.9M-8.1%$141.2M-26.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$19.2M0.0%$19.2M0.0%$19.2M0.0%$19.2M0.0%$19.2M0.0%$19.2M0.0%$19.2M0.0%$19.2M0.0%
Total Liabilities$2.1B+1.0%$2.2B+3.6%$2.2B+3.2%$2.1B-0.3%$2.1B-1.3%$2.1B-1.1%$2.1B+1.5%$2.1B+8.8%
Total Equity$202.7M+1.9%$201.4M+2.4%$200.3M+1.8%$201.8M+4.9%$198.9M+4.6%$196.6M+3.7%$196.6M+6.4%$192.3M+3.5%
Retained Earnings$76.8M+9.2%$73.5M+7.1%$72.4M+6.6%$73.1M+12.9%$70.4M+13.6%$68.7M+11.0%$67.9M+16.0%$64.8M+10.3%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

HNVR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HNVR quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$18.4M+943.2%-$2.5M-984.9%$8.3M+50.2%$2.7M+602.6%$1.8M+157.0%$284K-92.1%$5.5M+33.5%-$547K-160.4%
Depreciation & Amortization$500K+4.2%$509K+3.0%$324K+57.3%$502K+1.0%$480K-12.9%$494K-9.5%$206K-58.8%$497K-3.5%
Stock-Based CompensationN/A$358K-27.5%N/AN/AN/A$494K+29.7%N/AN/A
Capital Expenditures$442K+391.1%$184K-19.3%$234K-70.3%$317K-3.6%$90K-93.8%$228K-26.0%-$789K+121.6%$329K+4.1%
Free Cash Flow$18.0M+972.8%-$2.7M-4916.1%$8.0M+70.4%$2.4M+377.6%$1.7M+136.9%$56K-98.3%$4.7M+25.2%-$876K-248.5%
Investing Cash Flow-$33.8M-192.6%$1.9M-89.0%-$18.4M-148.1%-$14.9M-268.0%-$11.6M+29.2%$16.9M+122.2%$38.3M+127.9%$8.8M+119.0%
Financing Cash Flow-$37.9M-368.8%-$13.8M+30.3%$51.5M+332.3%$15.2M+285.1%$14.1M-41.5%-$19.8M-162.1%-$22.2M-118.8%-$8.2M-130.6%
Dividends Paid$742K-1.1%$746K-0.4%$762K+2.7%$748K+0.9%$750K+1.4%$749K+1.6%$742K+1.5%$741K+1.1%
Share BuybacksN/AN/A$1.3MN/AN/AN/AN/AN/A

HNVR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HNVR quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin20.8%+7.5pp9.8%+1.5pp0.2%-21.5pp19.4%-1.4pp13.3%+8.3pp8.3%-16.3pp21.7%-2.0pp20.8%-2.0pp
Return on Equity2.0%+0.8pp0.9%+0.2pp0.0%-2.0pp1.7%-0.1pp1.2%+0.8pp0.8%-1.4pp2.0%-0.1pp1.8%-0.1pp
Return on Assets0.2%+0.1pp0.1%0.0pp0.0%-0.2pp0.1%0.0pp0.1%+0.1pp0.1%-0.1pp0.2%0.0pp0.1%0.0pp
Debt-to-Equity10.52-0.1x10.77+0.1x10.90+0.1x10.55-0.6x10.62-0.6x10.65-0.5x10.76-0.5x11.10+0.5x
Asset Turnover0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x
FCF Margin92.0%+82.9pp-14.1%-14.4pp43.1%+17.0pp13.5%+18.6pp9.1%+36.1pp0.3%-19.6pp26.2%+2.5pp-5.1%-8.9pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Hanover Bancorp, Inc. HNVR FY2025 $73.3M $7.5M 10.2% $187.9M 29/100
CB Financial Services, Inc. (PA) CBFV FY2025 $43.5M $4.9M 11.3% $189.4M 22/100
BV Financial, Inc. BVFL FY2025 $39.6M $13.5M 34.1% $180.8M 66/100
CF Bankshares Inc. CFBK FY2025 $61.0M $17.5M 28.7% $224.0M 51/100
Landmark Bancorp Inc LARK FY2025 $70.6M $19K 0.0% $194.4M 34/100
Meridian Corporation MRBK FY2025 $126.9M $21.8M 17.2% $227.2M 33/100

Frequently Asked Questions

What is Hanover Bancorp, Inc.'s annual revenue?

Hanover Bancorp, Inc. (HNVR) reported $73.3M in total revenue for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hanover Bancorp, Inc.'s revenue growing?

Hanover Bancorp, Inc. (HNVR) revenue grew by 7.1% year-over-year, from $68.4M to $73.3M in fiscal year 2025.

Is Hanover Bancorp, Inc. profitable?

Yes, Hanover Bancorp, Inc. (HNVR) reported a net income of $7.5M in fiscal year 2025, with a net profit margin of 10.2%.

Hanover Bancorp, Inc. (HNVR) reported diluted earnings per share of $1.00 for fiscal year 2025. This represents a -39.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hanover Bancorp, Inc. (HNVR) had a net profit margin of 10.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Hanover Bancorp, Inc. (HNVR) paid $0.10 per share in dividends during fiscal year 2025.

Hanover Bancorp, Inc. (HNVR) has a return on equity of 3.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Hanover Bancorp, Inc. (HNVR) generated $12.2M in free cash flow during fiscal year 2025. This represents a 193.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Hanover Bancorp, Inc. (HNVR) generated $13.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Hanover Bancorp, Inc. (HNVR) had $2.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Hanover Bancorp, Inc. (HNVR) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Hanover Bancorp, Inc. (HNVR) spent $1.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Hanover Bancorp, Inc. (HNVR) had 7M shares outstanding as of fiscal year 2025.

Hanover Bancorp, Inc. (HNVR) had a debt-to-equity ratio of 10.90 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Hanover Bancorp, Inc. (HNVR) had a return on assets of 0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Hanover Bancorp, Inc. (HNVR) trades at 19.9x earnings, its market capitalization divided by net income of $9.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $187.9M as of Sep 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Hanover Bancorp, Inc. (HNVR) trades at 2.5x sales, its market capitalization divided by revenue of $75.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $187.9M as of Sep 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Hanover Bancorp, Inc. (HNVR) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Hanover Bancorp, Inc. (HNVR) has an earnings quality ratio of 1.74x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Hanover Bancorp, Inc. (HNVR) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top